Professor Barnes MD FRCPsych DSc is Professor of Clinical Psychiatry at Imperial College, and past Head of Department. He is also Honorary Consultant and clinical lead for clinical effectiveness in West London Mental Health Trust (WLMHT), and joint Head of the UK Prescribing Observatory for Mental Health (POMH-UK) in the Centre for Quality Improvemnet, Royal College of Psychiatrists.
Professor Barnes trained in psychiatry in London and Cambridge, developing a research interest in the psychopharmacology of schizophrenia. Past appointments include membership of the Committee on Safety of Medicines, member of the National Institute for Health and Clinical Excellence (NICE) Schizophrenia Guideline Group, chair of the Special Interest Group for Psychopharmacology (Royal College of Psychiatrists), President of the Royal Society of Medicine Psychiatry Section, and President of the British Association for Psychopharmacology.
Professor Barnes’ research in schizophrenia over the last 30 years has covered the phenomenology and neuropsychology of the condition, and substance use, but the focus has been its drug treatment and antipsychotic side effects, particularly movement disorders. This work has generated over 250 publications. He is currently leading two major clinical trials in treatment-resistant schizophrenia. He is a regular reviewer for a wide range of journals and funding bodies and serves on the editorial boards of several journals.
BARNES TRE, 1989, A RATING-SCALE FOR DRUG-INDUCED AKATHISIA, British Journal of Psychiatry, Vol:154, ISSN:0007-1250, Pages:672-676
et al., 2008, High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing, British Journal of Psychiatry, Vol:192, ISSN:0007-1250, Pages:435-439